TY  - JOUR

T1  - APPENDIX C: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

JO  - CONTINUUM: Lifelong Learning in Neurology

PY  - 2007/08/01

AU  - &NA;

ED  - 

DO  - DOI: 10.1212/01.con.0000284529.35649.1d

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 13

SP  - 203

EP  - 211

Y2  - 2024/12/26

ER  -